SSAK Partners, LLC.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• BioNTech SE1 trial
• ORIC Pharmaceuticals1 trial

Running trials

• Recruiting

  A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

  NCT07723248· Phase 3· ORIC Pharmaceuticals· Source

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  NCT06712316· Phase 2/3· BioNTech SE· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Prostate cancer1 recruiting